Joanne M. Donovan serves as Executive at CATABASIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Joanne M. Donovan has executed 8 insider transactions totaling $339.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved exercising options for 5,781 shares valued at $0.
Joanne M. Donovan currently holds 28,223 shares of CATABASIS PHARMACEUTICALS INC (CATB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joanne M. Donovan has been a net seller of CATB stock. They have purchased $0 and sold $339.5K worth of shares.
Joanne M. Donovan's most recent insider trade was on Aug 12, 2025, when they sold 5,781 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $13.39 |
| Discretionary |
| Sep 20, 2024 | EWTX | $202.6K | Sale | 7,162 | $28.29 | Discretionary |
| May 2, 2024 | EWTX | $69.6K | Sale | 3,682 | $18.91 | Discretionary |
| May 1, 2024 | EWTX | $0 | Option Exercise | 10,417 | $N/A | Discretionary |
| May 2, 2023 | EWTX | $29.0K | Sale | 3,254 | $8.90 | Discretionary |
| May 1, 2023 | EWTX | $0 | Option Exercise | 10,416 | $N/A | Discretionary |
| Jun 30, 2015 | CATB | $0 | Conversion | 409 | $N/A | Discretionary |